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Abstract 
The ‘macro-structural’ determinants of health, which include macroeconomic policy and social 
policy, significantly influence people’s living and working conditions, behaviours, and health. Trade 
policy is one example of a macro-structural determinant, with increasingly well recognised health 
outcomes. The health effects of macro-structural determinants such as trade policy are mediated 
through the policy and governance mechanisms of economic, social, and political institutions. Thus, 
responding to these determinants will require actions that generate institutional and policy change – 
and a politically-informed research approach. Some recent empirical work in the public and global 
health community has taken a more politically-informed approach to trade and health, however 
there is scope for considerable conceptual and methodological development. We describe how a 
perspective informed by political science might inform new ways of investigating and addressing 
trade policy to improve health outcomes. A range of theories and methods from policy studies are 
relevant, but particularly important will be application of institutional and ideational lenses of policy 
analysis, to understand better policy processes and inform avenues for macrostructural change. 
 
 
Main text 
A strong theme from the public health community regarding how to address health problems is the 
need to engage with the ‘upstream’ or structural determinants that shape individual behaviours and 
risk – the so called ‘causes of the causes’ of health outcomes. Interventions addressing disease risk 
at the individual level remain important, but many of the key determinants of health and wellbeing 
are considered to be best addressed at a population level (Marmot and Allen, 2014, McKee et al., 
2014). This concept is perhaps most clearly illustrated in the work of the World Health Organization’s 
Commission on the Social Determinants of Health (Commission on Social Determinants of Health, 
2008), and is described by various frameworks, several of which have been recently summarised in a 
report of the Canadian Council on Social Determinants of Health (Canadian Council on Social 
Determinants of Health, 2015). One of the most commonly seen of these is the Dahlgren and 
Whitehead (1991) rainbow model of the wider determinants of health (Dahlgren and Whitehead, 
1992) (Figure 1). The determinants on the outer layer of the model are those often described as the 
‘macro-structural’ determinants of health. They include macroeconomic policy and social policy and 
have significant influence over our living and working conditions, our lifestyle choices, and 
behaviours. Trade policy is one example of such a macro-structural determinant (Woodward et al., 
2001, Labonté and Schrecker, 2007, Blouin et al., 2009), with increasingly well recognised health 
outcomes (c.f. (Blouin et al., 2009, Labonte et al., 2011, Hawkes, 2006, Baker et al., 2014)). 
 
Figure 1. A conceptual model of the wider determinants of health 
 
Source: Dahlgren & Whitehead (1991) (Dahlgren and Whitehead, 1992); Canadian Council on Social 
Determinants of Health (Canadian Council on Social Determinants of Health, 2015). 
 
The health effects of macro-structural determinants such as trade policy are mediated through the 
policy and governance mechanisms of economic, social, and political institutions (Commission on 
Social Determinants of Health, 2008). Thus, responding to these determinants will typically require 
actions that generate institutional and policy change. Yet the public and global health communities 
have often struggled to apply approaches outside traditional biomedical or public health 
perspectives that might target these higher-level determining structures. In regard to trade and 
health research, several authors have already critiqued the limitations of the health sector in such 
ways (c.f. (McNamara, 2017, Walls et al., 2016b, Hanefeld et al., 2017)). McNamara (2017), for 
instance, argued that there has been “little methodological reflection on what theories, research 
designs or methods best inform analysis of trade and health” (McNamara, 2017). Here, we discuss 
how a perspective informed by political science might inform new ways of investigating and 
addressing trade policy to improve health outcomes.  
While there are an abundance of theories  developed  to explain features of policy-making or 
processes of policy change (John, 1998, Hill, 2005, Parsons, 1995), a common approach often taken 
is to consider the relevance of the so-called ‘3Is’ of interests, institutions, and ideas to explain policy 
outcomes (Hall, 1997). While many descriptions of policy-making might focus on the means by which 
stakeholders pursue their various interests, considering institutions and ideas has been shown to 
shed light on many critical features influencing the policy process beyond this initial starting point 
(c.f. (Beland, 2016, Beland, 2009, Smith, 2013a, Lowndes and Roberts, 2013)). Institutions include 
political, economic, and cultural structures – both formal structures (e.g. regulations, laws and ‘brick 
and mortar’ organizations) and less formal rules and patterns of behaviour. Ideational approaches 
consider aspects such as the way issues are framed or the roles that ideas play as motivating forces 
for change. Institutions and ideas are in many ways intertwined. Ideas help to conceptualise what is 
important within the remit of different institutional bodies, while institutions have their own ‘logics 
of appropriateness’ that reinforce certain ideas about what is appropriate action to take (Lowndes 
and Roberts, 2013, March and Olsen, 1984, Peters, 2008, March and Olsen, 2011). Thus, as Berman 
(2001) has noted, ideas persist over time through the process of institutionalisation (Berman, 2001). 
A growing number of scholars in the global health community have been considering how the 
interaction of institutions and ideas works to dictate which health issues are addressed (and which 
are not), by whom, and how (c.f. (Shiffman and Smith, 2007, Shearer et al., 2016, Smith et al., 2014, 
Walls et al., 2017, Shiffman et al., 2002)). But the challenges in addressing the macro-structural 
determinants of health remain. An example of these challenges, and the value of a more 
conceptually-informed policy analysis approach in helping to find a way forward, can be seen in the 
social determinants of health as described by the report of the WHO Commission on Social 
Determinants of Health (Commission on Social Determinants of Health, 2008). 
The WHO Commission on the Social Determinants of Health was established in 2005 to synthesise 
the evidence on how to address health inequities globally (Commission on Social Determinants of 
Health, 2008). The Commission’s overarching recommendations were to: 1) improve the daily living 
conditions; 2) tackle the inequitable distribution of power, money and resources; and 3) measure 
and understand the problem and assess the impact of action. Despite the high profile of this work, 
the overall lack of progress in addressing these recommendations has disappointed many in the 
global health community. 
The reasons for the lack of progress on the social determinants of health on government agendas 
are complex, but as several authors have described (c.f. (Scott-Samuel and Smith, 2015, Smith, 
2013a, Lynch, 2017, Smith and Joyce, 2012)), they can be attributed to institutionalised norms such 
as neoliberalism and a dominant biomedical approach to health that sit at odds with thinking about 
addressing broader social determinants of health. Neoliberalism, the prevailing economic paradigm 
since the 1980s, focuses on individual responsibility for health behaviours and outcomes, and fails to 
recognise the broader structural factors that have been shown to be crucial in explaining health 
outcomes (Navarro, 2007b, Rushton and Williams, 2012, Navarro, 2009, Navarro, 2007a, Scott-
Samuel and Smith, 2015, Smith, 2013b). Similarly, the biomedical approach looks for causes of illness 
proximal to the individual such as pathogens or individual behaviours rather than the broader 
structural factors that shape pathogen spread or influence the behaviour of individuals within a 
population (Glasgow and Schrecker, 2016, Bambra and Schrecker, 2015, Birn et al., 2009, Baum et 
al., 2013). These institutionalised ideas can either limit the consideration of the social determinants 
of health in agenda setting and policy development, or result in an their adaptation such that the 
policy as described in documents and vision statements is not reflected in actual on-the-ground 
implementation (Scott-Samuel and Smith, 2015, Smith, 2013b).  
As a result of the institutionalisation of ideas such as neoliberalism and a biomedical approach to 
health, often supported by powerful private actors who seek to further their particular interests 
(Moodie et al., 2013, Panjwani and Caraher, 2014, Scott et al., 2017), those seeking to promote the 
social determinants of health in government policy face substantial barriers to achieving change. For 
an example, the Public Health Responsibility Deal of England launched in March 2011, a partnership 
approach to addressing specific behaviours such as alcohol and food consumption. Involving 
collaborations between public, private and third-sector actors, this approach relies on voluntary 
private sector actions to help meet public heath goals, has been critiqued as a neoliberal policy that 
advances private sector values and interests – rather than an approach likely to be effective in 
addressing important public health concerns (Panjwani and Caraher, 2014). 
The institutional constraints to a more structural approach were recently described by Hunsmann 
(2012) in relation to HIV/AIDS planning. The author explored the political obstacles to integration of 
a broad set of approaches to addressing the social/structural drivers of HIV within donor agencies 
working in African settings, through an exploration of Tanzania in particular. He found that donor 
incentive structures worked against taking a  broader structural approach, despite thinking in the 
field that this approach was increasingly necessary to affect the drivers of HIV risk and transmission 
(Hunsmann, 2012 ).  
Alternatively, despite the Canadian government’s strong support for a social determinants approach 
to addressing health and inequities, several authors have described the challenges in Canadian 
public health practice, which  often focuses on inducing individual behavioural change, rather than 
strategies addressing the social determinants of health that shape such behaviours (Brassolotti et al., 
2014, Raphael, 2003, McIntyre et al., 2013).  
An analysis of nutritional concerns in the European Union’s Common Agricultural Policy described 
obstacles in the Commission’s legal mandate that impede addressing nutrition through agricultural 
policy – institutionalising an approach instead focused on consumer education strategies to improve 
nutrition. This analysis also uncovered sectoral differences in opinion regarding the appropriateness 
of addressing nutrition within agricultural policy – an example of ideational differences between 
different governing institutions, that can impede policy development (Walls et al., 2016a). 
In various ways, then, research from a number of areas of health helps to point to the institutional 
and ideational obstacles that may also serve as barriers to achieving more healthy international 
trade policy. One key factor is the strong industry influence over the process, dominating the ideas 
around what appropriate goals are to pursue in international trade (principally growth and revenue 
oriented), as well as reflecting a dominant idea of free market access and minimal regulation (in 
favour of health and social goals, at least) as supporting such growth (c.f. (Walls et al., 2015, Hawkins 
and Holden, 2016, McNeill et al., 2017)). Some recent empirical work taking this more politically-
informed approach to trade and health has also been conducted (c.f. (Thow et al., 2015, Friel et al., 
2016, McNamara and Labonté, 2017, Thow et al., 2014)), including by Schram and colleagues in this 
Special Issue (Schram, 2018); however,  there is scope for considerable conceptual and 
methodological development.  
Research to improve understanding of the health impact of trade policy is critically important and 
this is fortunately an area of growing research interest. However despite increasing recognition of 
the importance of macrostructural factors, including trade policy, to health outcomes, systems of 
policy making and governance are often structurally aligned in ways that hinder action on these 
issues. To go beyond descriptions of problematic outcomes to inform positive change, will likely 
require a more explicit political economy approach that challenges the systemic arrangements 
perpetuating the health outcomes of concern. A range of theories and methods from policy studies 
will be relevant to explore the mechanisms that hinder change. One way of starting can be to apply 
institutional and ideational lenses of policy analysis. Research addressing interests will be important,  
complemented by analyses of power in regard to how it is attained, distributed and exercised, and 
how organised interests function and propagate favourable arrangements (Lukes, 2005, Lukes, 
1993). But also important will be explicit institutional and ideational approaches to understanding 
policy processes and informing avenues for macrostructural change. 
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